Dishman Pharmaceuticals strengthens on plan to raise up to Rs 200 crore through QIP

14 Aug 2014 Evaluate

Dishman Pharmaceuticals & Chemicals is currently trading at Rs 129.50, up by 1.25 points or 0.97% from its previous closing of Rs 128.25 on the BSE.

The scrip opened at Rs 129.00 and has touched a high and low of Rs 132.60 and Rs 128.15 respectively. So far 93848 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 159.80 on 22-Jul-2014 and a 52 week low of Rs 39.65 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs 148.55 and Rs 126.00 respectively. The current market cap of the company is Rs 1034.94 crore.

The promoters holding in the company stood at 61.40% while Institutions and Non-Institutions held 14.75% and 23.85% respectively.

Dishman Pharmaceuticals & Chemicals has received an approval to raise up to Rs 200 crore by way of issue of shares to Qualified Institutional Investors (QIP), subject to approval of members. The board of directors at its meeting held on August 13, 2014 has approved for the same.

Dishman Pharmaceuticals is engaged in the manufacturing of active pharmaceutical ingredients (APIs) intermediates. The Company operates in two segments: contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats and specialty chemicals.

Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.